SPONSOR
Keymed Biosciences Co.Ltd
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 1
NCT05775042 Phase 2
Recruiting
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
IgA Nephropathy
NCT06947980 Phase 2
Recruiting
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
NCT07011524 Phase 2
Recruiting
Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
Asthma
NCT06412185 Phase 1
Recruiting
Single Dose Escalation Study of CM383 in Healthy Volunteers
Alzheimer Disease